Wolfgang Rudolph Ralph Stoiber

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA.

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. The company is headquartered in New York, NY.

MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts.

Dansk Shell A/S operates as energy and petrochemicals companies. The firm produces biofuels. It engages in oil and gas exploration, production, and sale of gasoline and diesel. The company was founded in 1913 and is headquartered in Fredericia, Denmark.

Part of Smith & Nephew plc, Smith & Nephew Endoscopy, Inc. develops medical technology products used principally in tissue, bone, skin, and soft tissue repair. The company is based in Andover, MA.

Tytex A/S provides medical textile products. Its products include continence care post surgery, ostomy and hernia, wound dressing and IV fixation, hip protection and pregnancy & nursing. The company was founded in 1971 and is headquartered in Ikast, Denmark.

GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.

Part of Shell Plc, Shell Research Ltd. is a British company that provides business support services. The company is based in London, UK.

Lundbeck Pharma A/S markets and sells medicines within Central Nervous System. It specializes in various illnesses and conditions such as depression, Schizophrenia, anxiety, alcohol dependence, and Parkinson's and Alzheimer's diseases. The company was founded on January 1, 1988 and is headquartered in Valby, Denmark.

H. Lundbeck AS trades pharmaceutical and healthcare products. It provides drugs for the treatment of depression, schizophrenia, alzheimers, and Parkinsons diseases. The company was founded in 1948 and is headquartered in Lysaker, Norway.

Catacap Management A/S (Catacap Management) is a private equity firm founded in 2011byVilhelmEigilHanhPetersen and Jens Jorgen Hanh Petersen. The firm is headquartered in Copehagen, Denamrk.

Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden.

Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston.

HASLE Industries A/S specializes in producing refractory materials for high-temperature industries. The private company is based in Ronne, Denmark. The Danish company offers a range of technical design services, including material selection, drawings, and heat loss calculations, in addition to its refractory product line. HASLE Industries produces a variety of high-grade refractory solutions, such as low cement castables, accessories, and precast elements, including insulating, easy flowing, and gunning versions for optimized installation.

AntibioTx ApS develops and manufactures pharmaceutical products. The private company is based in Kongens Lyngby, Denmark.

Union Therapeutics A/S operates as a clinical stage pharmaceutical company which focuses on the treatment of inflammatory skin disease. It also centers in the development of molecules exhibiting immunological and microbiological effects. The company is headquartered in Hellerup, Denmark.

StemMedical A/S provides a cell-enriched fat grafting solution for cosmetic treatments. The company is based in Soborg, Denmark. The Danish company was founded in 2014 by Stig-Frederik Trojahn Kølle.

Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then.

Part of Ginkgo Bioworks Holdings, Inc., Project Beacon Covid-19 LLC is a social benefit organization founded in 2020. The company is based in Boston, MA. The company's mission is to support the scaling of COVID-19 testing by improving capacity, availability, access, and affordability. Project Beacon Covid-19 was acquired by Ginkgo Bioworks Holdings, Inc. on January 19, 2022.

Orsobio, Inc. is a clinical-stage biopharmaceutical company that focuses on developing therapies to treat obesity and other severe metabolic disorders, such as type 2 diabetes, NASH, and severe dyslipidemias. The company is based in Palo Alto, CA. The company has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism. Orsobio has a team of physicians and scientists who are dedicated to developing therapies to treat organ failure in patients with severe metabolic disorders. The company was founded by Mani Subramanian, who has been the CEO since incorporation.

Transmedica A/S provides patients with specialized treatment. It operates as health care provider, which recruits and sends health workers and agency staff to public and private hospitals in the Scandinavian healthcare sector. The firm's activities are divided into main business units temporary help; private hospitals and clinics; and other health services. It also runs clinics specialized in weight loss surgery, eye surgery, orthopedics, rheumatology, and psychiatry. The company was founded by Karsten Ramløv Svendsen in 1990 and is headquartered in Copenhagen, Denmark.